Original document(12 pages)  中文版
    The present invention belongs to the field of medicine and health-care product for cardiovascular system. In the concrete, it relates to a compound perilla seed oil and its capsule preparation. It can be used for preventing and curing the diseases of hypertension, hyperlipemia and angiocardiopathy. Its composition contains (by wt%) 0.01-0.05% of vitamin C, 0.03-0.12% of water. 0.1-0.5% of vitamin E and the rest is perilla seed oil.
Application Number
申请号		 200510105322 Application Date
申请日		 2005.09.23
Title 名称 Compound perillaseed oil and its capsule pill
Publication Number
公开号		 1935186 Publication Date
公开日		 2007.03.28
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K36/535;A61K9/20;A61P9/00;A61P3/06;A61K31/355
Applicant(s) Name
申请人		 Fujian San'ai Pharmaceutical Co., Ltd.
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 xiayan beng
More information 更  多  信  息


 Related patents information
Preparation of 13-hexyl fibrauretine and its anti-virus and antibacterial action
Preparation of 13-hexyl berberine salt and its anti-virus and antibacterial action
Use of chloride 13-hexyl berberine and chloride 13-hexyl palmatine in preparation of medicine for treating moist tetter, dermatitis and psoriasis
Use of chloride 13-hexyl berberine and chloride 13-hexyl palmatine in preparation of medicine for treating vagina and oral cavity infection-inflammation
Use of chloride 13-hexyl berberine in preparation of medicine for treating peptic ulcer and bacteriological gastroenteritis
Use of chloride 13-hexyl berberine and chloride 13-hexyl palmatine in preparation of medicine for treating skin mucosa herpes viral infection
Novel 13-n-octylberberine derivative with antineoplastic action
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.